Human Dil-Acetylated  Low Density Lipoprotein (Human DiI-Ac-LDL)

Details:

Product Description

Low Density Lipoprotein, or LDL, is converted from very Low Density Lipoprotein (VLDL). Its main function is to transport cholesterol to cells throughout the body. Cholesterol is transported to the liver for synthesis of cholic acid. It can be used to study receptor - mediated endocytosis. Plasma derived LDL can be used to study the oxidative role of LDL in function and metabolism, especially in diseases such as atherosclerosis.

Acetylated LDL is a class of modified LDL. LDL contains the unmodified apolipoprotein and can be used to study the transport and endocytosis of normal cholesterol. When the lysine residue of LDL apolipoprotein is acetylated, the LDL complex no longer binds to the LDL receptor. However, modified LDL is more likely to bind to "Scavenger" receptors in endothelial cells and microglial nerve cells. Therefore, Ac-LDL can be used to study the function of these cells.

Acetylated LDL from healthy human plasma, tested negative for Hepatitis C, HIV-I and HIV-II antibodies. This product is sterile packaging and can be directly diluted for use.

This product is a red fluorescent labeled acetylated human low density lipoprotein, which is Ac-LDL labeled with fluorescent probe DiI (1,1'-dioctadecyl-3,3,3',3' -tetramethyl-indocarbocyanine perchlorate).  When cells are labeled with DiI-Ac-LDL, the lipoprotein is degraded by lysosomal enzymes and DiI accumulates in the inner membrane of the cells, which can be used to detect the absorption of modified LDL.  It can be used to label vascular endothelial cells, macrophages, and endothelial progenitor cells (EPC), to identify and select these cells, and to study the endocytosis of different cell lines on modified LDL.  Each batch of DiI-Ac-LDL supplied by our company was tested for labeling specificity by bovine aorta endothelial cells and mouse macrophages to ensure consistency of results.  

YEASEN provides Human DiI-Ac-LDL in aseptic packaging and can be directly diluted for use.  In addition to DiI-Ac-LDL, we also offer unlabeled Ac-LDL, Ox-LDL (oxidative modification) and unmodified LDL, etc.  

Product Properties

Concentration

1.0-3.0 mg/mL by Lowry

Appearance

liquid

Buffer Components

0.01 μM EDTA in PBS, pH 7.4

Shipping and Storage

The products are shipped with ice pack and can be stored at 4℃ and away from light for 6 weeks.

Do not freeze! Be sure to use aseptic operation!

Cautions

1. The dilution liquid of this product is very unstable, so it is recommended to use it immediately.

2. The product will see a small amount of precipitation after long-term preservation, which is a normal phenomenon. Centrifuge at low speed for 2 min to remove the precipitate and obtain the clarification solution.

3. For your safety and health, please wear lab coats and disposable gloves for operation.

4. For research use only.

Instructions

1.Under sterile conditions, Human DiI-Ac-LDL was diluted to 20-50 µg/mL in cell culture medium.

2. Add into living cells and culture at 37℃ for 4 hours.

3.At the end of incubation, the medium containing Human DiI-Ac-LDL was sucked out and washed several times with the medium without probe.

4.Fluorescence microscopy or flow cytometry was used for detection according to experimental requirements.  

① Fluorescence microscope observation  

Standard rhodamine excitation: emission filter (or suggested wavelength: Ex/Em=549 nm/565 nm); If necessary, please use PBS containing 3% formaldehyde for fixation, do not use methanol or acetone for fixation, because Dil is easily soluble in organic solvents.  [Note] Positive cells should be set as control.  

② Cell sorting (flow cytometry)  

The cells were treated with trypsin or made into a single cell suspension by adding EDTA. Suitable labeled purified cells were selected as negative and positive controls for flow sorting (GATE).  (Recommended wavelength Ex:514/549 nm;  Em: 565 nm).

Citations & References:

[1] Zhang F, Zhu Y, Chen J, et al. Efficient endothelial and smooth muscle cell differentiation from human pluripotent stem cells through a simplified insulin-free culture system. Biomaterials. 2021;271:120713. doi:10.1016/j.biomaterials.2021.120713(IF:12.479)

[2] Wang L, Zhang F, Duan F, et al. Homozygous MESP1 knock-in reporter hESCs facilitated cardiovascular cell differentiation and myocardial infarction repair. Theranostics. 2020;10(15):6898-6914. Published 2020 May 23. doi:10.7150/thno.42347(IF:8.579)

[3] Li HY, Liu XL, Liu YT, et al. Matrix sieving-enforced retrograde transcytosis regulates tissue accumulation of C-reactive protein. Cardiovasc Res. 2019;115(2):440-452. doi:10.1093/cvr/cvy181(IF:7.014)

[4] Chen W, Ding Y, Liu D, Lu Z, Wang Y, Yuan Y. Kaposi's sarcoma-associated herpesvirus vFLIP promotes MEndT to generate hybrid M/E state for tumorigenesis. PLoS Pathog. 2021;17(12):e1009600. Published 2021 Dec 22. doi:10.1371/journal.ppat.1009600(IF:6.823)

[5] Zhang BF, Jiang H, Chen J, Hu Q, Yang S, Liu XP. Silica-coated magnetic nanoparticles labeled endothelial progenitor cells alleviate ischemic myocardial injury and improve long-term cardiac function with magnetic field guidance in rats with myocardial infarction. J Cell Physiol. 2019;234(10):18544-18559. doi:10.1002/jcp.28492(IF:6.384)

[6] Wang Y, Li T, Li H, et al. CORO1A regulates lipoprotein uptake in Leydig cells exposed to cadmium. Ecotoxicol Environ Saf. 2022;232:113255. doi:10.1016/j.ecoenv.2022.113255(IF:6.291)

[7] Yu Y, Li X, Li Y, et al. Derivation and Characterization of Endothelial Cells from Porcine Induced Pluripotent Stem Cells. Int J Mol Sci. 2022;23(13):7029. Published 2022 Jun 24. doi:10.3390/ijms23137029(IF:6.208)

[8] Ni X, Yang ZZ, Ye LQ, et al. Establishment of an in vitro safety assessment model for lipid-lowering drugs using same-origin human pluripotent stem cell-derived cardiomyocytes and endothelial cells. Acta Pharmacol Sin. 2022;43(1):240-250. doi:10.1038/s41401-021-00621-8(IF:6.150)

[9] Quan Y, Shan X, Hu M, et al. YAP inhibition promotes endothelial cell differentiation from pluripotent stem cell through EC master transcription factor FLI1. J Mol Cell Cardiol. 2022;163:81-96. doi:10.1016/j.yjmcc.2021.10.004(IF:5.000)

[10] Liu R, Zheng Y, Han T, Lan J, He L, Shi J. Angiogenic Actions of Paeoniflorin on Endothelial Progenitor Cells and in Ischemic Stroke Rat Model. Am J Chin Med. 2021;49(4):863-881. doi:10.1142/S0192415X21500415(IF:4.667)

[11] Zhang F, Wang L, Li Y, et al. Optimizing mesoderm progenitor selection and three-dimensional microniche culture allows highly efficient endothelial differentiation and ischemic tissue repair from human pluripotent stem cells. Stem Cell Res Ther. 2017;8(1):6. Published 2017 Jan 23. doi:10.1186/s13287-016-0455-4(IF:4.211)

[12] Gu X, Xie S, Hong D, Ding Y. An in vitro model of foam cell formation induced by a stretchable microfluidic device. Sci Rep. 2019;9(1):7461. Published 2019 May 16. doi:10.1038/s41598-019-43902-3(IF:4.011)

[13] Li X, Yu Y, Wei R, et al. In vitro and in vivo study on angiogenesis of porcine induced pluripotent stem cell-derived endothelial cells. Differentiation. 2021;120:10-18. doi:10.1016/j.diff.2021.05.003(IF:3.880)

[14] Zhu P, Jiang W, He S, et al. Panax notoginseng saponins promote endothelial progenitor cell angiogenesis via the Wnt/β-catenin pathway. BMC Complement Med Ther. 2021;21(1):53. Published 2021 Feb 8. doi:10.1186/s12906-021-03219-z(IF:3.659)

[15] Wei R, Lv J, Li X, et al. Derivation of endothelial cells from porcine induced pluripotent stem cells by optimized single layer culture system. J Vet Sci. 2020;21(1):e9. doi:10.4142/jvs.2020.21.e9(IF:1.503)

COA Please fill out the COA application form

Catalog No.:*

Name*

phone Number:*

Lot:*

Email*

Country:*

Company/Institute:*